You just read:

Steba Biotech's TOOKAD® Vascular Photodynamic Therapy Maintains Significant Reduction in Overall Progression and Conversion to Radical Therapy in Low-risk Prostate Cancer Patients at 4 Years

News provided by

Steba Biotech

20 Jun, 2018, 08:00 BST